J T Chambers
Overview
Explore the profile of J T Chambers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
527
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jaffe J, Chambers J
J Intellect Disabil Res
. 2005 May;
49(Pt 6):463-5.
PMID: 15882396
Background: Endometrial adenocarcinoma is very uncommon in women under 40 years of age. Case: A 39-year-old woman with tuberous sclerosis and severe intellectual disability presented with irregular bleeding unresponsive to...
2.
Pal L, Parkash V, Chambers J
Obstet Gynecol
. 2003 May;
101(5 Pt 2):1130-2.
PMID: 12738126
Background: Tumor-associated blood eosinophilia and tumor-associated tissue eosinophilia have been described in association with a spectrum of neoplasms. A case of uterine leiomyosarcoma exhibiting both blood and tissue eosinophilia is...
3.
Chambers J, Rutherford T, Schwartz P, Carcangiu M, Chambers S, Baker L
Int J Gynecol Cancer
. 2003 Mar;
13(2):216-22.
PMID: 12657127
A pilot study investigated topotecan (Hycamtin, GlaxoSmithKline, Philadelphia, PA), a topoisomerase I inhibitor, in treating uterine serous carcinoma, a typically unresponsive aggressive tumor. Fifteen patients were surgically staged, then treated...
4.
Jaffe J, Timell A, Eisenberg M, Chambers J
J Intellect Disabil Res
. 2002 Oct;
46(Pt 7):569-74.
PMID: 12354313
Background: The present study was designed to determine the prevalence of abnormal cervical cytology in an institutionalized population with intellectual disability. Method: A retrospective review of charts for 162 women...
5.
Pejovic T, Koul A, Olsen D, Chambers J
Eur J Gynaecol Oncol
. 2002 Jan;
22(5):336-8.
PMID: 11766733
The purpose of the study was to examine BRCA1 germline mutation and its relationship to BRCA1 expression in two patients, a mother and a daughter, both diagnosed with uterine papillary...
6.
Milliken N, Freund K, Pregler J, Reed S, Carlson K, Derman R, et al.
J Womens Health Gend Based Med
. 2001 Sep;
10(7):627-36.
PMID: 11571092
Between 1996 and 1999, 18 academic health centers were awarded the designation of National Center of Excellence (CoE) in Women's Health by the Office on Women's Health within the Department...
7.
Toy E, Chambers J, Kacinski B, Flick M, Chambers S
Gynecol Oncol
. 2001 Feb;
80(2):194-200.
PMID: 11161859
Objective: We have previously shown that the macrophage colony-stimulating factor receptor (CSF-1R) and its ligand, CSF-1, together predict poor prognosis in epithelial ovarian carcinoma. The activated or phosphorylated form of...
8.
Azodi M, Chambers S, Rutherford T, Kohorn E, Schwartz P, Chambers J
Gynecol Oncol
. 1999 Jun;
73(3):348-53.
PMID: 10366458
Objective: The aim of this study was to review the management and outcome of patients with adenocarcinoma in situ of the cervix and to evaluate the significance of endocervical cone...
9.
Schwartz P, Rutherford T, Chambers J, Kohorn E, Thiel R
Gynecol Oncol
. 1999 Jan;
72(1):93-9.
PMID: 9889037
Purpose: The aim of this study was to compare the progression-free and overall survivals of women with advanced ovarian cancer treated with neoadjuvant chemotherapy followed by surgery with those treated...
10.
Odunsi K, Peck L, Kohorn E, Parkash V, Cracchiolo B, Chambers J, et al.
Gynecol Oncol
. 1998 Aug;
70(1):100-4.
PMID: 9698483
We report a patient who developed metastatic gestational choriocarcinoma following delivery of a normal, healthy child that, however, was anemic and required blood transfusion. The patient developed secondary postpartum hemorrhage...